Dr. Marwa Zaki

Position: Cluster Expert - Middle East Regulatory Affairs and Post Market Surveillance, Fresenius Medical Care
Categories: Speakers 2026

Dr. Marwa Zaki is a pharmacist with extensive expertise in pharmaceutical regulatory affairs, medical device regulatory affairs, pharmacovigilance, and medical device vigilance across the Middle East and GCC region. She earned her Bachelor’s Degree in Pharmaceutical Sciences in 2006 and has developed a distinguished career dedicated to regulatory compliance, patient safety, quality systems, and healthcare product lifecycle management.

Dr. Zaki completed advanced professional studies in Regulatory Affairs, Pharmacovigilance, Pricing, and Market Access through Harvard Medical School, Boston, USA. She also holds a Medical Devices Regulatory Affairs Certification from the Regulatory Affairs Professionals Society (RAPS) and has been a Certified Qualified Person for Pharmacovigilance (QPPV) since 2016 through the Arab Union of Pharmaceuticals and Medical Appliances (AUPAM).

She is currently pursuing a Master’s Degree in Pharmacovigilance and Pharmacoepidemiology at the University of Bordeaux, France, where her research focuses on strengthening pharmacovigilance oversight and patient safety systems within the healthcare sector.

In recognition of her contributions to medicine safety and pharmacovigilance, Dr. Zaki received the GCC Pharmacovigilance Excellence Award in 2023.

Currently serving as Cluster Expert – Middle East at Fresenius Medical Care, Dr. Zaki possesses a rare combination of expertise spanning three highly specialized disciplines: pharmaceutical regulatory affairs, medical device regulatory affairs, and pharmacovigilance/medical device vigilance. Throughout her career in the dialysis industry, including leading global healthcare organizations, she has managed regulatory, quality, and safety activities for both medicinal products and medical devices across numerous countries in the GCC, Levant, and wider Middle East region.

Dr. Zaki is passionate about advancing patient safety, strengthening healthcare regulatory systems, promoting effective risk communication, and supporting innovation while ensuring the highest standards of quality, compliance, and public health protection.